Brind.

AM Best Assigns Indicative Credit Ratings to Elevance Health, Inc.

1 report, 1 independent Updated Thu 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

On November 12, 2026, AM Best assigned indicative Long-Term Issue Credit Ratings to Elevance Health, Inc. The ratings include "bbb+" for senior unsecured issues, "bbb" for subordinated issues, and "bbb-" for preferred stock issues, with a stable outlook. The company's financial leverage was reported at 40.8% as of September 30, 2026.

From finanznachrichten.de

Why it matters

Some supportBrind's analysis of the reports

The rating reflects that Elevance Health maintains adequate earnings before interest and taxes interest coverage of over six times for 2025 and through the third quarter of 2026. The company's financial flexibility and liquidity are noted as good, supported by its large commercial paper program and revolving credit facility.

From finanznachrichten.de

Who's involved

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • TD CowenSpeculative

    The new credit rating might influence valuation models and price objective setting.

  • Leerink partnersSpeculative

    The new credit rating may be used as a key input for financial analysis and target setting.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped